GlassScriptPhysician profile
Casey A Ogburn
NPI 1396063947
$3,744.10
in general payments reported to CMS, 2019-2025
40 companies · $726 in 2025
The $726 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.96 · 2020: $108 · 2021: $607 · 2022: $1,095 · 2023: $455 · 2024: $729 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $504.11 | 2021-2025 | Veozah, Xtandi |
| Abbvie INC. | $312.66 | 2019-2022 | |
| Myovant Sciences INC. | $300.39 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $225.50 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $201.79 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $178.32 | 2021-2024 | Slynd |
| Pfizer INC. | $162.86 | 2022-2025 | |
| Hologic Sales and Service, LLC | $155.61 | 2023-2025 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Therapeuticsmd, INC. | $155.47 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $143.76 | 2021-2025 | |
| Coopersurgical, INC. | $128.03 | 2020-2023 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Mylan Pharmaceuticals INC. | $119.60 | 2021-2022 | |
| Gynesonics, INC. | $101.75 | 2022 | |
| Sage Therapeutics, LLC | $100.19 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $81.46 | 2021-2024 | Gardasil, Gardasil 9 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $67.35 | 2022-2023 | Twirla |
| Exact Sciences Corporation | $66.78 | 2024-2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $58.32 | 2023-2025 | Accrufer |
| Avion Pharmaceuticals | $53.40 | 2021-2022 | |
| Minerva Surgical, INC | $51.24 | 2022 | |
| Evofem Biosciences, INC. | $50.52 | 2021-2022 | |
| Daiichi Sankyo INC. | $48.34 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.93 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $44.40 | 2021 | |
| Sanara Medtech INC. | $42.47 | 2025 | Celleraterx |
| Scynexis, INC. | $36.07 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.73 | 2022 | |
| Lilly USA, LLC | $31.73 | 2025 | Zepbound |
| Applied Medical Resources Corporation | $28.80 | 2022 | |
| Convatec INC. | $25.39 | 2023 | |
| Meditrina | $24.54 | 2024 | |
| Millicent US INC | $22.60 | 2025 | Femlyv |
| Supernus Pharmaceuticals, INC. | $21.91 | 2025 | Qelbree |
| Smith+Nephew, INC. | $20.17 | 2025 | Stravix |
| Baxter Healthcare | $19.75 | 2023 | Tisseel |
| Dexcom, INC. | $19.34 | 2023 | Dexcom G6 Transmitter |
| Optumhealth Care Solutions, LLC | $17.82 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Radius Health, INC. | $14.69 | 2024 | Tymlos |
| Medicem INC. | $14.32 | 2025 | |
| Currax Pharmaceuticals LLC | $13.99 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Ogburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.